Skip to main content
Arctic Bioscience logo

Arctic Bioscience — Investor Relations & Filings

Ticker · ABS ISIN · NO0010859580 LEI · 549300Z2HW6I989Q2C78 OL Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2024-06-26 Report Publication Anno…
Country NO Norway
Listing OL ABS

About Arctic Bioscience

https://arctic-bioscience.com/

Arctic Bioscience is a biotechnology company that develops and commercializes pharmaceutical and nutraceutical products derived from marine membrane lipids. The company utilizes proprietary technology to extract bioactive compounds from herring roe, sourced from sustainable, MSC-certified fisheries. Its nutraceutical product line, marketed under the brand name Romega, consists of high-DHA Omega-3 phospholipid extracts. The pharmaceutical division is focused on developing a novel drug candidate for the treatment of mild-to-moderate psoriasis, aligning with its mission to create therapies for autoimmune disorders. The company's work is supported by extensive research and development to validate the efficacy of its marine-based ingredients.

Recent filings

Filing Released Lang Actions
Arctic Bioscience - New positive data showing anti-inflammatory effects of phospholipid esters from herring roe in immune cells
Report Publication Announcement Classification · 95% confidence The document is a short announcement detailing new positive scientific data regarding the investigational medicine HRO350, presented at a workshop. It includes quotes from the CEO and Medical Director, mentions ongoing clinical trials (Phase 2b for psoriasis), and references a poster presentation. Crucially, it ends with the statement: "The poster will be made available on the IR tab on the company's webpage." This structure—a brief press release announcing the existence and availability of research/data elsewhere—strongly suggests it is an announcement about a report or presentation, rather than the full report itself. Since it is not a standard regulatory filing (like 10-K, ER, or IR), and it announces the publication of information (a poster), the most appropriate classification is Report Publication Announcement (RPA). It is too specific for the general Regulatory Filings (RNS) fallback.
2024-06-26 English
Arctic Bioscience - Q1 2024 Operational update - Progress according to plan
Interim / Quarterly Report Classification · 95% confidence The document is an 'Operational Update' for Q1 2024, which includes specific financial key figures (revenues, gross profit, EBITDA, liquidity) and management commentary on business performance and outlook. It is a comprehensive quarterly update containing substantive financial data, fitting the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-04-29 English
Arctic Bioscience - 1. kv. 2024 oppdatering - Fremdrift i henhold til plan
Interim / Quarterly Report Classification · 100% confidence The document is a quarterly update from Arctic Bioscience for Q1 2024. It contains key financial highlights (sales, EBITDA, liquidity), operational updates on the HeROPA study, and forward-looking statements. It provides substantive financial data and analysis for a specific interim period, fitting the definition of an Interim/Quarterly Report (IR). It is not merely an announcement of a report, as it contains the actual financial figures and management commentary. Q1 2024
2024-04-29 Norwegian
Arctic Bioscience - Protokoll fra ordinær generalforsamling
AGM Information Classification · 100% confidence The document is explicitly titled "PROTOKOLL FRA GENERALFORSAMLING I ARCTIC BIOSCIENCE AS" (MINUTES FROM ORDINARY GENERAL MEETING IN ARCTIC BIOSCIENCE AS). It details the proceedings, agenda items (like approval of annual accounts, remuneration, election of board members, and granting of capital increase authorization), and the final signed protocol from the meeting held on April 26, 2024. This content perfectly matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting (AGM). Although it references the Annual Report (section 4), the document itself is the official record of the meeting.
2024-04-26 English
Arctic Bioscience - Minutes of the Annual General Meeting
AGM Information Classification · 100% confidence The document is explicitly titled "PROTOKOLL FRA GENERALFORSAMLING I ARCTIC BIOSCIENCE AS" (MINUTES FROM ORDINARY GENERAL MEETING IN ARCTIC BIOSCIENCE AS). It details the proceedings, agenda items (like approval of annual accounts, remuneration, election of board members, and granting of capital increase authorization), and the final signed protocol from the meeting held on April 26, 2024. This content perfectly matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting (AGM). Although it references the Annual Report (section 4), the document itself is the official record of the meeting.
2024-04-26 English
Arctic Bioscience - Protokoll fra ordinær generalforsamling
AGM Information Classification · 99% confidence The document title is "Arctic Bioscience - Protokoll fra ordinær generalforsamling" (Protocol from the Annual General Meeting). The text confirms that the Annual General Meeting (AGM) was held and that the protocol is attached. Since this document is a short announcement/protocol summary referencing the meeting and attaching the full minutes, it fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM. It is not a DEF 14A (Remuneration) or DVA (Voting Results), but the core material related to the meeting itself.
2024-04-26 Norwegian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.